ICN DROPS INTEREST IN HOFFMANN-LA ROCHE

ICN DROPS INTEREST IN HOFFMANN-LA ROCHE

ICN Pharmaceuticals Inc. says it has sold the 8.6 percent stake in Swiss

drug-industry giant